and more recently, metabolic-dysfunction associated steatohepatitis (MASH)
Longer, well organized, double-blind RCTs with larger sample sizes in individuals with or without T2D are anticipated in order to investigate the safety, activity, and limitations of both drug categories to decrease OSA severity and improve cardiovascular outcomes
What Areas Can Be Treated
Delivery Method (Injection vs Oral) As covered in detail in the Best Forms of BPC-157, oral BPC-157 may be cleared faster but has local effects on the GI tract , while injectables lead to systemic distribution
Most patients who experience fatigue report improvement within 4-8 weeks as the body adapts to reduced appetite and caloric intake
Monitor renal function in patients reporting adverse reactions to Saxenda that could lead to volume depletion, especially during initation and escalation of Saxenda Severe Gastrointestinal Adverse Reactions: Use of Saxenda has been associated with gastrointestinal adverse reactions, sometimes severe
